Unknown

Dataset Information

Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence.


ABSTRACT: Neuroblastoma survivors show signs of immunosenescence early after therapy in CD8+ T cell compartment and elevated plasma TNF-α but in later follow-up immune recovery comes into play. Whether the recovery phenotype is long lasting or transient remains to be elucidated, however, late adverse effects often occur in childhood cancer survivors.

SUBMITTER: Laznickova P 

PROVIDER: S-EPMC7754117 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature